AIDS Dementia Complex
Information
- Disease name
- AIDS Dementia Complex
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02678767 | Completed | Phase 2 | Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS | February 2015 | September 2017 |
NCT00000702 | Completed | Phase 3 | A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection | August 1990 | |
NCT00000709 | Completed | Phase 3 | An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts | February 1990 | |
NCT00000738 | Completed | Phase 1 | Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 | June 1994 | |
NCT00000867 | Completed | Phase 2 | A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC) | December 1996 | July 2001 |
NCT00002044 | Completed | N/A | A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases | ||
NCT00002163 | Completed | Phase 3 | A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex | ||
NCT00002209 | Completed | Phase 1 | Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy | ||
NCT00002246 | Completed | Phase 3 | A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex | October 1997 | March 1999 |
NCT00000657 | Completed | Phase 2 | Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex | September 1992 | |
NCT02128828 | Completed | Phase 2 | Effect of Cenicriviroc on HIV Neurocognitive Impairment | April 2014 | June 2016 |
NCT02159027 | Completed | Phase 2/Phase 3 | Maraviroc and NeuroAIDS Pathogenesis | June 2015 | February 2019 |
NCT00459693 | Terminated | N/A | PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD) | April 9, 2007 | April 6, 2014 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015526